BlackRock’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.71M | Sell |
|
|||||
|
2022
Q4 | $2.85M | Sell |
|
|||||
|
2022
Q3 | $6.53M | Buy |
|
|||||
|
2022
Q2 | $8.07M | Buy |
|
|||||
|
2022
Q1 | $16.8M | Sell |
|
|||||
|
2021
Q4 | $21M | Sell |
|
|||||
|
2021
Q3 | $18.8M | Buy |
|
|||||
|
2021
Q2 | $16.7M | Buy |
|
|||||
|
2021
Q1 | $18.9M | Buy |
|
|||||
|
2020
Q4 | $10.8M | Buy |
|
|||||
|
2020
Q3 | $9.88M | Sell |
|
|||||
|
2020
Q2 | $8.77M | Buy |
|
|||||
|
2020
Q1 | $5.9M | Buy |
|
|||||
|
2019
Q4 | $10.8M | Sell |
|
|||||
|
2019
Q3 | $4.21M | Buy |
|
|||||
|
2019
Q2 | $5.76M | Buy |
|
|||||
|
2019
Q1 | $7.09M | Buy |
|
|||||
|
2018
Q4 | $3.59M | Sell |
|
|||||
|
2018
Q3 | $9.43M | Buy |
|
|||||
|
2018
Q2 | $10.7M | Buy |
|
|||||
|
2018
Q1 | $25.5M | Sell |
|
|||||
|
2017
Q4 | $14.8M | Buy |
|
|||||
|
2017
Q3 | $11.3M | Buy |
|
|||||
|
2017
Q2 | $5.05M | Buy |
|
|||||
|
2017
Q1 | $5.79M | Buy |
|